Shopping Cart 0
Cart Subtotal
USD 0

GenePOC Inc - Product Pipeline Analysis, 2019 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 750

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 1500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 2250
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

GenePOC Inc (GenePOC), a subsidiary of Debiopharm Group, is a medical device company that develops rapid molecular devices for providing targeted therapy. The company offers on-the-spot diagnostic devices for achieving optimal patient management. It offers diagnostic instruments based on a novel centripetal technology platform. GenePOC also provides automated point-of-care molecular diagnostic system that facilitates early detection and the prevention of infectious diseases. The company's POC diagnostic system is employed in the detection of respiratory tract infections, neonatal infections, gastrointestinal tract, and others. GenePOC is headquartered in Quebec City, Quebec, Canada.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company GenePOC Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

GenePOC Inc Company Overview

GenePOC Inc Company Snapshot

GenePOC Inc Pipeline Products and Ongoing Clinical Trials Overview

GenePOC Inc-Pipeline Analysis Overview

GenePOC Inc-Key Facts

GenePOC Inc-Major Products and Services

GenePOC Inc Pipeline Products by Development Stage

GenePOC Inc Ongoing Clinical Trials by Trial Status

GenePOC Inc Pipeline Products Overview

GenePOC GBS DS Assay

GenePOC GBS DS Assay Product Overview

GenePOC GBS DS Assay Clinical Trial

revogene-Bacillus atrophaeus subsp. globigii Assay

revogene-Bacillus atrophaeus subsp. globigii Assay Product Overview

revogene-Bacillus subtilis Assay

revogene-Bacillus subtilis Assay Product Overview

revogene-Campylobacter jejuni Assay

revogene-Campylobacter jejuni Assay Product Overview

revogene-Candida albicans Assay

revogene-Candida albicans Assay Product Overview

revogene-Clostridium difficile Assay

revogene-Clostridium difficile Assay Product Overview

revogene-Enterococcus faecalis Assay

revogene-Enterococcus faecalis Assay Product Overview

revogene-Escherichia coli Assay

revogene-Escherichia coli Assay Product Overview

revogene-Influenza A Assay

revogene-Influenza A Assay Product Overview

revogene-Respiratory Tract Infections Assay

revogene-Respiratory Tract Infections Assay Product Overview

revogene-Salmonella enterica Assay

revogene-Salmonella enterica Assay Product Overview

revogene-Sexually Transmitted Infections Assay

revogene-Sexually Transmitted Infections Assay Product Overview

revogene-Staphylococcus Assay

revogene-Staphylococcus Assay Product Overview

Triplex Molecular Diagnostic Assay

Triplex Molecular Diagnostic Assay Product Overview

GenePOC Inc-Key Competitors

GenePOC Inc-Key Employees

GenePOC Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

GenePOC Inc, Recent Developments

May 16, 2019: GenePOC Obtains FDA Clearance for its GenePOC Carba Test in the US

Apr 11, 2019: GenePOC obtains CE marked for its GenePOC Carba Test

Mar 21, 2019: GenePOC obtains FDA clearance for its GenePOC Strep A Test in the US

Mar 22, 2018: Novacyt Signs Assay Development Contract for Diagnosis of Respiratory Infections with GenePOC

Mar 22, 2018: Novacyt Signs Assay Development Contract for Diagnosis of Respiratory Infections with GenePOC

Feb 19, 2018: GenePOC Launches Its revogene Instrument and GBS LB Test in Canada

Nov 28, 2017: GenePOC Launches Its GenePOC CDiff Test In The United States

Oct 12, 2017: GenePOC Launches its new GenePOC GBS DS Test

Sep 27, 2017: Genepoc to Attend EMMD in Noortwijk, the Netherlands, From October 11th to 13th

Jun 01, 2017: GenePOC announces FDA clearance for GBS LB test

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

GenePOC Inc Pipeline Products by Equipment Type

GenePOC Inc Pipeline Products by Development Stage

GenePOC Inc Ongoing Clinical Trials by Trial Status


List Of Table

List of Tables

GenePOC Inc Pipeline Products and Ongoing Clinical Trials Overview

GenePOC Inc Pipeline Products by Equipment Type

GenePOC Inc Pipeline Products by Indication

GenePOC Inc Ongoing Clinical Trials by Trial Status

GenePOC Inc, Key Facts

GenePOC Inc, Major Products and Services

GenePOC Inc Number of Pipeline Products by Development Stage

GenePOC Inc Pipeline Products Summary by Development Stage

GenePOC Inc Ongoing Clinical Trials by Trial Status

GenePOC Inc Ongoing Clinical Trials Summary

GenePOC GBS DS Assay-Product Status

GenePOC GBS DS Assay-Product Description

GenePOC GBS DS Assay-Prospective Study for Clinical Validation of the Molecular-based GenePOC Carba Assay for the Detection and Differentiation of Carbapenemase Genes of Gram-negative Bacteria (blaIMP, blaKPC, blaNDM, blaOXA-48-like and blaVIM) in Rectal Swab Samples From Patients Suspected of Being Colonized. The Targeted Organisms are Enterobacteriaceae, Acinetobacter Baumannii, and Pseudomonas Aeruginosa

revogene-Bacillus atrophaeus subsp. globigii Assay-Product Status

revogene-Bacillus atrophaeus subsp. globigii Assay-Product Description

revogene-Bacillus subtilis Assay-Product Status

revogene-Bacillus subtilis Assay-Product Description

revogene-Campylobacter jejuni Assay-Product Status

revogene-Campylobacter jejuni Assay-Product Description

revogene-Candida albicans Assay-Product Status

revogene-Candida albicans Assay-Product Description

revogene-Clostridium difficile Assay-Product Status

revogene-Clostridium difficile Assay-Product Description

revogene-Enterococcus faecalis Assay-Product Status

revogene-Enterococcus faecalis Assay-Product Description

revogene-Escherichia coli Assay-Product Status

revogene-Escherichia coli Assay-Product Description

revogene-Influenza A Assay-Product Status

revogene-Influenza A Assay-Product Description

revogene-Respiratory Tract Infections Assay-Product Status

revogene-Respiratory Tract Infections Assay-Product Description

revogene-Salmonella enterica Assay-Product Status

revogene-Salmonella enterica Assay-Product Description

revogene-Sexually Transmitted Infections Assay-Product Status

revogene-Sexually Transmitted Infections Assay-Product Description

revogene-Staphylococcus Assay-Product Status

revogene-Staphylococcus Assay-Product Description

Triplex Molecular Diagnostic Assay-Product Status

Triplex Molecular Diagnostic Assay-Product Description

GenePOC Inc, Key Employees

GenePOC Inc, Other Locations

Glossary

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

GenePOC Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Rna Diagnostics Inc

Amico Corp

Xagenic Inc

Diagnostics Biochem Canada Inc

Summary

GenePOC Inc (GenePOC), a subsidiary of Debiopharm Group, is a medical device company that develops rapid molecular devices for providing targeted therapy. The company offers on-the-spot diagnostic devices for achieving optimal patient management. It offers diagnostic instruments based on a novel centripetal technology platform. GenePOC also provides automated point-of-care molecular diagnostic system that facilitates early detection and the prevention of infectious diseases. The company's POC diagnostic system is employed in the detection of respiratory tract infections, neonatal infections, gastrointestinal tract, and others. GenePOC is headquartered in Quebec City, Quebec, Canada.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company GenePOC Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

GenePOC Inc Company Overview

GenePOC Inc Company Snapshot

GenePOC Inc Pipeline Products and Ongoing Clinical Trials Overview

GenePOC Inc-Pipeline Analysis Overview

GenePOC Inc-Key Facts

GenePOC Inc-Major Products and Services

GenePOC Inc Pipeline Products by Development Stage

GenePOC Inc Ongoing Clinical Trials by Trial Status

GenePOC Inc Pipeline Products Overview

GenePOC GBS DS Assay

GenePOC GBS DS Assay Product Overview

GenePOC GBS DS Assay Clinical Trial

revogene-Bacillus atrophaeus subsp. globigii Assay

revogene-Bacillus atrophaeus subsp. globigii Assay Product Overview

revogene-Bacillus subtilis Assay

revogene-Bacillus subtilis Assay Product Overview

revogene-Campylobacter jejuni Assay

revogene-Campylobacter jejuni Assay Product Overview

revogene-Candida albicans Assay

revogene-Candida albicans Assay Product Overview

revogene-Clostridium difficile Assay

revogene-Clostridium difficile Assay Product Overview

revogene-Enterococcus faecalis Assay

revogene-Enterococcus faecalis Assay Product Overview

revogene-Escherichia coli Assay

revogene-Escherichia coli Assay Product Overview

revogene-Influenza A Assay

revogene-Influenza A Assay Product Overview

revogene-Respiratory Tract Infections Assay

revogene-Respiratory Tract Infections Assay Product Overview

revogene-Salmonella enterica Assay

revogene-Salmonella enterica Assay Product Overview

revogene-Sexually Transmitted Infections Assay

revogene-Sexually Transmitted Infections Assay Product Overview

revogene-Staphylococcus Assay

revogene-Staphylococcus Assay Product Overview

Triplex Molecular Diagnostic Assay

Triplex Molecular Diagnostic Assay Product Overview

GenePOC Inc-Key Competitors

GenePOC Inc-Key Employees

GenePOC Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

GenePOC Inc, Recent Developments

May 16, 2019: GenePOC Obtains FDA Clearance for its GenePOC Carba Test in the US

Apr 11, 2019: GenePOC obtains CE marked for its GenePOC Carba Test

Mar 21, 2019: GenePOC obtains FDA clearance for its GenePOC Strep A Test in the US

Mar 22, 2018: Novacyt Signs Assay Development Contract for Diagnosis of Respiratory Infections with GenePOC

Mar 22, 2018: Novacyt Signs Assay Development Contract for Diagnosis of Respiratory Infections with GenePOC

Feb 19, 2018: GenePOC Launches Its revogene Instrument and GBS LB Test in Canada

Nov 28, 2017: GenePOC Launches Its GenePOC CDiff Test In The United States

Oct 12, 2017: GenePOC Launches its new GenePOC GBS DS Test

Sep 27, 2017: Genepoc to Attend EMMD in Noortwijk, the Netherlands, From October 11th to 13th

Jun 01, 2017: GenePOC announces FDA clearance for GBS LB test

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

GenePOC Inc Pipeline Products by Equipment Type

GenePOC Inc Pipeline Products by Development Stage

GenePOC Inc Ongoing Clinical Trials by Trial Status


List Of Table

List of Tables

GenePOC Inc Pipeline Products and Ongoing Clinical Trials Overview

GenePOC Inc Pipeline Products by Equipment Type

GenePOC Inc Pipeline Products by Indication

GenePOC Inc Ongoing Clinical Trials by Trial Status

GenePOC Inc, Key Facts

GenePOC Inc, Major Products and Services

GenePOC Inc Number of Pipeline Products by Development Stage

GenePOC Inc Pipeline Products Summary by Development Stage

GenePOC Inc Ongoing Clinical Trials by Trial Status

GenePOC Inc Ongoing Clinical Trials Summary

GenePOC GBS DS Assay-Product Status

GenePOC GBS DS Assay-Product Description

GenePOC GBS DS Assay-Prospective Study for Clinical Validation of the Molecular-based GenePOC Carba Assay for the Detection and Differentiation of Carbapenemase Genes of Gram-negative Bacteria (blaIMP, blaKPC, blaNDM, blaOXA-48-like and blaVIM) in Rectal Swab Samples From Patients Suspected of Being Colonized. The Targeted Organisms are Enterobacteriaceae, Acinetobacter Baumannii, and Pseudomonas Aeruginosa

revogene-Bacillus atrophaeus subsp. globigii Assay-Product Status

revogene-Bacillus atrophaeus subsp. globigii Assay-Product Description

revogene-Bacillus subtilis Assay-Product Status

revogene-Bacillus subtilis Assay-Product Description

revogene-Campylobacter jejuni Assay-Product Status

revogene-Campylobacter jejuni Assay-Product Description

revogene-Candida albicans Assay-Product Status

revogene-Candida albicans Assay-Product Description

revogene-Clostridium difficile Assay-Product Status

revogene-Clostridium difficile Assay-Product Description

revogene-Enterococcus faecalis Assay-Product Status

revogene-Enterococcus faecalis Assay-Product Description

revogene-Escherichia coli Assay-Product Status

revogene-Escherichia coli Assay-Product Description

revogene-Influenza A Assay-Product Status

revogene-Influenza A Assay-Product Description

revogene-Respiratory Tract Infections Assay-Product Status

revogene-Respiratory Tract Infections Assay-Product Description

revogene-Salmonella enterica Assay-Product Status

revogene-Salmonella enterica Assay-Product Description

revogene-Sexually Transmitted Infections Assay-Product Status

revogene-Sexually Transmitted Infections Assay-Product Description

revogene-Staphylococcus Assay-Product Status

revogene-Staphylococcus Assay-Product Description

Triplex Molecular Diagnostic Assay-Product Status

Triplex Molecular Diagnostic Assay-Product Description

GenePOC Inc, Key Employees

GenePOC Inc, Other Locations

Glossary

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

GenePOC Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Rna Diagnostics Inc

Amico Corp

Xagenic Inc

Diagnostics Biochem Canada Inc